Skip to main content

Advertisement

SpringerLink
Log in

Silybin and metabolic disorders

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Violi F, Pignatelli P, Basili S (2010) Nutrition, supplements, and vitamins in platelet function and bleeding. Circulation 121(8):1033–1044. https://doi.org/10.1161/CIRCULATIONAHA.109.880211

    Article  PubMed  Google Scholar 

  2. Violi F, Pignatelli P (2012) Platelet oxidative stress and thrombosis. Thromb Res 129(3):378–381. https://doi.org/10.1016/j.thromres.2011.12.002

    Article  CAS  PubMed  Google Scholar 

  3. Violi F, Pignatelli P, Pignata C, Plebani A, Rossi P, Sanguigni V, Carnevale R, Soresina A, Finocchi A, Cirillo E, Catasca E, Angelico F, Loffredo L (2013) Reduced atherosclerotic burden in subjects with genetically determined low oxidative stress. Arterioscler Thromb Vasc Biol 33(2):406–412. https://doi.org/10.1161/ATVBAHA.112.300438

    Article  CAS  PubMed  Google Scholar 

  4. Polimeni L, Del Ben M, Baratta F, Perri L, Albanese F, Pastori D, Violi F, Angelico F (2015) Oxidative stress: new insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World J Hepatol 7(10):1325–1336. https://doi.org/10.4254/wjh.v7.i10.1325

    Article  PubMed  PubMed Central  Google Scholar 

  5. Santilli F, Lapenna D, La Barba S, Davi G (2015) Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus. Free Radical Biol Med 80:101–110. https://doi.org/10.1016/j.freeradbiomed.2014.12.010

    Article  CAS  Google Scholar 

  6. Sciacqua A, Perticone M, Tripepi G, Addesi D, Cassano V, Maio R, Sesti G, Perticone F (2018) Metabolic and vascular effects of silybin in hypertensive patients with high one-hour post-load plasma glucose. Intern Emerg Med. https://doi.org/10.1007/s11739-018-1951-6

    Article  PubMed  Google Scholar 

  7. Loguercio C, Festi D (2011) Silybin and the liver: from basic research to clinical practice. World J Gastroenterol 17(18):2288–2301. https://doi.org/10.3748/wjg.v17.i18.2288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Trouillas P, Marsal P, Svobodova A, Vostalova J, Gazak R, Hrbac J, Sedmera P, Kren V, Lazzaroni R, Duroux JL, Walterova D (2008) Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. J Phys Chem A 112(5):1054–1063. https://doi.org/10.1021/jp075814h

    Article  CAS  PubMed  Google Scholar 

  9. Lirussi F, Beccarello A, Zanette G, De Monte A, Donadon V, Velussi M, Crepaldi G (2002) Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent. Diabetes Nutr Metab 15(4):222–231

    CAS  PubMed  Google Scholar 

  10. Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M (2006) The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 20(12):1036–1039. https://doi.org/10.1002/ptr.1988

    Article  CAS  PubMed  Google Scholar 

  11. Federico A, Trappoliere M, Tuccillo C, de Sio I, Di Leva A, Del Vecchio Blanco C, Loguercio C (2006) A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations. Gut 55(6):901–902. https://doi.org/10.1136/gut.2006.091967

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Germano G, Sanguigni V, Pignatelli P, Caccese D, Lenti L, Ragazzo M, Lauro R, Violi F (2004) Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors. J Hypertens 22(6):1151–1156

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Medical Specialties, I Clinica Medica, Atherothrombosis Centre, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy

    Pasquale Pignatelli & Danilo Menichelli

  2. Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy

    Roberto Carnevale

Authors
  1. Pasquale Pignatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberto Carnevale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Danilo Menichelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pasquale Pignatelli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement on human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pignatelli, P., Carnevale, R. & Menichelli, D. Silybin and metabolic disorders. Intern Emerg Med 14, 1–3 (2019). https://doi.org/10.1007/s11739-018-1968-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-018-1968-x

Keywords

Search

Navigation